Global Tumor Markers Immunoassay Market Size, Status and Forecast 2018-2025

2018-12-07 / 3900.00 / Pharma & Healthcare / 107 Pages

Description

In 2017, the global Tumor Markers Immunoassay market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global Tumor Markers Immunoassay status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tumor Markers Immunoassay development in United States, Europe and China.

The key players covered in this study
Clarity Diagnostics, LLC
CTK Biotech, Inc
DIALAB GmbH
Ortho Clinical Diagnostics
Polymedco, Inc
DIAsource ImmunoAssays SA
DRG International, Inc
Fujirebio US, Inc
Bioscience (Tianjin) Diagnostic Technology Co., Ltd
Boson Biotech Co., Ltd
Qualigen, Inc
Randox Laboratories, Ltd
Roche Diagnostic Corporation
Siemens Healthineers
Syntron Bioresearch, Inc
Teco Diagnostics
Thermo Fisher Scientific, Inc
Tosoh Bioscience, Inc
Diametra
DiaSorin S.p.A

Market segment by Type, the product can be split into
ProGRP
PSA (complexed, free, total))
SCC (squamous cell carcinoma antigen)
Serum HER-2/neu
Thyroglobulin
CA 72-4
Others

Market segment by Application, split into
Liver Cancer
Breast Cancer
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Tumor Markers Immunoassay status, future forecast, growth opportunity, key market and key players.
To present the Tumor Markers Immunoassay development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Tumor Markers Immunoassay are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Content

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Tumor Markers Immunoassay Market Size Growth Rate by Type (2013-2025)
1.4.2 ProGRP
1.4.3 PSA (complexed, free, total))
1.4.4 SCC (squamous cell carcinoma antigen)
1.4.5 Serum HER-2/neu
1.4.6 Thyroglobulin
1.4.7 CA 72-4
1.4.8 Others
1.5 Market by Application
1.5.1 Global Tumor Markers Immunoassay Market Share by Application (2013-2025)
1.5.2 Liver Cancer
1.5.3 Breast Cancer
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Tumor Markers Immunoassay Market Size
2.2 Tumor Markers Immunoassay Growth Trends by Regions
2.2.1 Tumor Markers Immunoassay Market Size by Regions (2013-2025)
2.2.2 Tumor Markers Immunoassay Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Tumor Markers Immunoassay Market Size by Manufacturers
3.1.1 Global Tumor Markers Immunoassay Revenue by Manufacturers (2013-2018)
3.1.2 Global Tumor Markers Immunoassay Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Tumor Markers Immunoassay Market Concentration Ratio (CR5 and HHI)
3.2 Tumor Markers Immunoassay Key Players Head office and Area Served
3.3 Key Players Tumor Markers Immunoassay Product/Solution/Service
3.4 Date of Enter into Tumor Markers Immunoassay Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Tumor Markers Immunoassay Market Size by Type (2013-2018)
4.2 Global Tumor Markers Immunoassay Market Size by Application (2013-2018)

5 United States
5.1 United States Tumor Markers Immunoassay Market Size (2013-2018)
5.2 Tumor Markers Immunoassay Key Players in United States
5.3 United States Tumor Markers Immunoassay Market Size by Type
5.4 United States Tumor Markers Immunoassay Market Size by Application

6 Europe
6.1 Europe Tumor Markers Immunoassay Market Size (2013-2018)
6.2 Tumor Markers Immunoassay Key Players in Europe
6.3 Europe Tumor Markers Immunoassay Market Size by Type
6.4 Europe Tumor Markers Immunoassay Market Size by Application

7 China
7.1 China Tumor Markers Immunoassay Market Size (2013-2018)
7.2 Tumor Markers Immunoassay Key Players in China
7.3 China Tumor Markers Immunoassay Market Size by Type
7.4 China Tumor Markers Immunoassay Market Size by Application

8 Japan
8.1 Japan Tumor Markers Immunoassay Market Size (2013-2018)
8.2 Tumor Markers Immunoassay Key Players in Japan
8.3 Japan Tumor Markers Immunoassay Market Size by Type
8.4 Japan Tumor Markers Immunoassay Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Tumor Markers Immunoassay Market Size (2013-2018)
9.2 Tumor Markers Immunoassay Key Players in Southeast Asia
9.3 Southeast Asia Tumor Markers Immunoassay Market Size by Type
9.4 Southeast Asia Tumor Markers Immunoassay Market Size by Application

10 India
10.1 India Tumor Markers Immunoassay Market Size (2013-2018)
10.2 Tumor Markers Immunoassay Key Players in India
10.3 India Tumor Markers Immunoassay Market Size by Type
10.4 India Tumor Markers Immunoassay Market Size by Application

11 Central & South America
11.1 Central & South America Tumor Markers Immunoassay Market Size (2013-2018)
11.2 Tumor Markers Immunoassay Key Players in Central & South America
11.3 Central & South America Tumor Markers Immunoassay Market Size by Type
11.4 Central & South America Tumor Markers Immunoassay Market Size by Application

12 International Players Profiles
12.1 Clarity Diagnostics, LLC
12.1.1 Clarity Diagnostics, LLC Company Details
12.1.2 Company Description and Business Overview
12.1.3 Tumor Markers Immunoassay Introduction
12.1.4 Clarity Diagnostics, LLC Revenue in Tumor Markers Immunoassay Business (2013-2018)
12.1.5 Clarity Diagnostics, LLC Recent Development
12.2 CTK Biotech, Inc
12.2.1 CTK Biotech, Inc Company Details
12.2.2 Company Description and Business Overview
12.2.3 Tumor Markers Immunoassay Introduction
12.2.4 CTK Biotech, Inc Revenue in Tumor Markers Immunoassay Business (2013-2018)
12.2.5 CTK Biotech, Inc Recent Development
12.3 DIALAB GmbH
12.3.1 DIALAB GmbH Company Details
12.3.2 Company Description and Business Overview
12.3.3 Tumor Markers Immunoassay Introduction
12.3.4 DIALAB GmbH Revenue in Tumor Markers Immunoassay Business (2013-2018)
12.3.5 DIALAB GmbH Recent Development
12.4 Ortho Clinical Diagnostics
12.4.1 Ortho Clinical Diagnostics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Tumor Markers Immunoassay Introduction
12.4.4 Ortho Clinical Diagnostics Revenue in Tumor Markers Immunoassay Business (2013-2018)
12.4.5 Ortho Clinical Diagnostics Recent Development
12.5 Polymedco, Inc
12.5.1 Polymedco, Inc Company Details
12.5.2 Company Description and Business Overview
12.5.3 Tumor Markers Immunoassay Introduction
12.5.4 Polymedco, Inc Revenue in Tumor Markers Immunoassay Business (2013-2018)
12.5.5 Polymedco, Inc Recent Development
12.6 DIAsource ImmunoAssays SA
12.6.1 DIAsource ImmunoAssays SA Company Details
12.6.2 Company Description and Business Overview
12.6.3 Tumor Markers Immunoassay Introduction
12.6.4 DIAsource ImmunoAssays SA Revenue in Tumor Markers Immunoassay Business (2013-2018)
12.6.5 DIAsource ImmunoAssays SA Recent Development
12.7 DRG International, Inc
12.7.1 DRG International, Inc Company Details
12.7.2 Company Description and Business Overview
12.7.3 Tumor Markers Immunoassay Introduction
12.7.4 DRG International, Inc Revenue in Tumor Markers Immunoassay Business (2013-2018)
12.7.5 DRG International, Inc Recent Development
12.8 Fujirebio US, Inc
12.8.1 Fujirebio US, Inc Company Details
12.8.2 Company Description and Business Overview
12.8.3 Tumor Markers Immunoassay Introduction
12.8.4 Fujirebio US, Inc Revenue in Tumor Markers Immunoassay Business (2013-2018)
12.8.5 Fujirebio US, Inc Recent Development
12.9 Bioscience (Tianjin) Diagnostic Technology Co., Ltd
12.9.1 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Company Details
12.9.2 Company Description and Business Overview
12.9.3 Tumor Markers Immunoassay Introduction
12.9.4 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Revenue in Tumor Markers Immunoassay Business (2013-2018)
12.9.5 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Recent Development
12.10 Boson Biotech Co., Ltd
12.10.1 Boson Biotech Co., Ltd Company Details
12.10.2 Company Description and Business Overview
12.10.3 Tumor Markers Immunoassay Introduction
12.10.4 Boson Biotech Co., Ltd Revenue in Tumor Markers Immunoassay Business (2013-2018)
12.10.5 Boson Biotech Co., Ltd Recent Development
12.11 Qualigen, Inc
12.12 Randox Laboratories, Ltd
12.13 Roche Diagnostic Corporation
12.14 Siemens Healthineers
12.15 Syntron Bioresearch, Inc
12.16 Teco Diagnostics
12.17 Thermo Fisher Scientific, Inc
12.18 Tosoh Bioscience, Inc
12.19 Diametra
12.20 DiaSorin S.p.A

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details


Table of Figures

List of Tables and Figures

Table Tumor Markers Immunoassay Key Market Segments
Table Key Players Tumor Markers Immunoassay Covered
Table Global Tumor Markers Immunoassay Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Tumor Markers Immunoassay Market Size Market Share by Type 2013-2025
Figure ProGRP Figures
Table Key Players of ProGRP
Figure PSA (complexed, free, total)) Figures
Table Key Players of PSA (complexed, free, total))
Figure SCC (squamous cell carcinoma antigen) Figures
Table Key Players of SCC (squamous cell carcinoma antigen)
Figure Serum HER-2/neu Figures
Table Key Players of Serum HER-2/neu
Figure Thyroglobulin Figures
Table Key Players of Thyroglobulin
Figure CA 72-4 Figures
Table Key Players of CA 72-4
Figure Others Figures
Table Key Players of Others
Table Global Tumor Markers Immunoassay Market Size Growth by Application 2013-2025 (Million US$)
Figure Liver Cancer Case Studies
Figure Breast Cancer Case Studies
Figure Others Case Studies
Figure Tumor Markers Immunoassay Report Years Considered
Table Global Tumor Markers Immunoassay Market Size 2013-2025 (Million US$)
Figure Global Tumor Markers Immunoassay Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Tumor Markers Immunoassay Market Size by Regions 2013-2025 (Million US$)
Table Global Tumor Markers Immunoassay Market Size by Regions 2013-2018 (Million US$)
Table Global Tumor Markers Immunoassay Market Share by Regions 2013-2018
Figure Global Tumor Markers Immunoassay Market Share by Regions 2013-2018
Figure Global Tumor Markers Immunoassay Market Share by Regions 2018
Table Market Top Trends
Table Global Tumor Markers Immunoassay Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Tumor Markers Immunoassay Market Share by Manufacturers (2013-2018)
Figure Global Tumor Markers Immunoassay Market Share by Manufacturers in 2018
Table Global Tumor Markers Immunoassay Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Tumor Markers Immunoassay Product/Solution/Service
Table Date of Enter into Tumor Markers Immunoassay Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Tumor Markers Immunoassay Market Size by Type (2013-2018) (Million US$)
Table Global Tumor Markers Immunoassay Market Size Share by Type (2013-2018)
Figure Global Tumor Markers Immunoassay Market Size Market Share by Type (2013-2018)
Table Global Tumor Markers Immunoassay Market Size by Application (2013-2018) (Million US$)
Table Global Tumor Markers Immunoassay Market Size Share by Application (2013-2018)
Figure Global Tumor Markers Immunoassay Market Size Market Share by Application (2013-2018)
Figure Global Tumor Markers Immunoassay Revenue Market Share by Application in 2017
Figure United States Tumor Markers Immunoassay Market Size 2013-2018 (Million US$)
Table United States Key Players Tumor Markers Immunoassay Revenue (2017-2018) (Million US$)
Table United States Key Players Tumor Markers Immunoassay Market Share (2017-2018)
Table United States Tumor Markers Immunoassay Market Size by Type (2013-2018) (Million US$)
Table United States Tumor Markers Immunoassay Market Share by Type (2013-2018)
Table United States Tumor Markers Immunoassay Market Size by Application (2013-2018) (Million US$)
Table United States Tumor Markers Immunoassay Market Share by Application (2013-2018)
Figure Europe Tumor Markers Immunoassay Market Size 2013-2018 (Million US$)
Table Europe Key Players Tumor Markers Immunoassay Revenue (2017-2018) (Million US$)
Table Europe Key Players Tumor Markers Immunoassay Market Share (2017-2018)
Table Europe Tumor Markers Immunoassay Market Size by Type (2013-2018) (Million US$)
Table Europe Tumor Markers Immunoassay Market Share by Type (2013-2018)
Table Europe Tumor Markers Immunoassay Market Size by Application (2013-2018) (Million US$)
Table Europe Tumor Markers Immunoassay Market Share by Application (2013-2018)
Figure China Tumor Markers Immunoassay Market Size 2013-2018 (Million US$)
Table China Key Players Tumor Markers Immunoassay Revenue (2017-2018) (Million US$)
Table China Key Players Tumor Markers Immunoassay Market Share (2017-2018)
Table China Tumor Markers Immunoassay Market Size by Type (2013-2018) (Million US$)
Table China Tumor Markers Immunoassay Market Share by Type (2013-2018)
Table China Tumor Markers Immunoassay Market Size by Application (2013-2018) (Million US$)
Table China Tumor Markers Immunoassay Market Share by Application (2013-2018)
Figure Japan Tumor Markers Immunoassay Market Size 2013-2018 (Million US$)
Table Japan Key Players Tumor Markers Immunoassay Revenue (2017-2018) (Million US$)
Table Japan Key Players Tumor Markers Immunoassay Market Share (2017-2018)
Table Japan Tumor Markers Immunoassay Market Size by Type (2013-2018) (Million US$)
Table Japan Tumor Markers Immunoassay Market Share by Type (2013-2018)
Table Japan Tumor Markers Immunoassay Market Size by Application (2013-2018) (Million US$)
Table Japan Tumor Markers Immunoassay Market Share by Application (2013-2018)
Figure Southeast Asia Tumor Markers Immunoassay Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Tumor Markers Immunoassay Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Tumor Markers Immunoassay Market Share (2017-2018)
Table Southeast Asia Tumor Markers Immunoassay Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Tumor Markers Immunoassay Market Share by Type (2013-2018)
Table Southeast Asia Tumor Markers Immunoassay Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Tumor Markers Immunoassay Market Share by Application (2013-2018)
Figure India Tumor Markers Immunoassay Market Size 2013-2018 (Million US$)
Table India Key Players Tumor Markers Immunoassay Revenue (2017-2018) (Million US$)
Table India Key Players Tumor Markers Immunoassay Market Share (2017-2018)
Table India Tumor Markers Immunoassay Market Size by Type (2013-2018) (Million US$)
Table India Tumor Markers Immunoassay Market Share by Type (2013-2018)
Table India Tumor Markers Immunoassay Market Size by Application (2013-2018) (Million US$)
Table India Tumor Markers Immunoassay Market Share by Application (2013-2018)
Figure Central & South America Tumor Markers Immunoassay Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Tumor Markers Immunoassay Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Tumor Markers Immunoassay Market Share (2017-2018)
Table Central & South America Tumor Markers Immunoassay Market Size by Type (2013-2018) (Million US$)
Table Central & South America Tumor Markers Immunoassay Market Share by Type (2013-2018)
Table Central & South America Tumor Markers Immunoassay Market Size by Application (2013-2018) (Million US$)
Table Central & South America Tumor Markers Immunoassay Market Share by Application (2013-2018)
Table Clarity Diagnostics, LLC Company Details
Table Clarity Diagnostics, LLC Revenue in Tumor Markers Immunoassay Business (2013-2018) (Million US$)
Figure Clarity Diagnostics, LLC Revenue Growth Rate in Tumor Markers Immunoassay Business (2013-2018)
Table Clarity Diagnostics, LLC Recent Development
Table CTK Biotech, Inc Company Details
Table CTK Biotech, Inc Revenue in Tumor Markers Immunoassay Business (2013-2018)(Million US$)
Figure CTK Biotech, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2013-2018)
Table CTK Biotech, Inc Recent Development
Table DIALAB GmbH Company Details
Table DIALAB GmbH Revenue in Tumor Markers Immunoassay Business (2013-2018)(Million US$)
Figure DIALAB GmbH Revenue Growth Rate in Tumor Markers Immunoassay Business (2013-2018)
Table DIALAB GmbH Recent Development
Table Ortho Clinical Diagnostics Company Details
Table Ortho Clinical Diagnostics Revenue in Tumor Markers Immunoassay Business (2013-2018)(Million US$)
Figure Ortho Clinical Diagnostics Revenue Growth Rate in Tumor Markers Immunoassay Business (2013-2018)
Table Ortho Clinical Diagnostics Recent Development
Table Polymedco, Inc Company Details
Table Polymedco, Inc Revenue in Tumor Markers Immunoassay Business (2013-2018)(Million US$)
Figure Polymedco, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2013-2018)
Table Polymedco, Inc Recent Development
Table DIAsource ImmunoAssays SA Company Details
Table DIAsource ImmunoAssays SA Revenue in Tumor Markers Immunoassay Business (2013-2018)(Million US$)
Figure DIAsource ImmunoAssays SA Revenue Growth Rate in Tumor Markers Immunoassay Business (2013-2018)
Table DIAsource ImmunoAssays SA Recent Development
Table DRG International, Inc Company Details
Table DRG International, Inc Revenue in Tumor Markers Immunoassay Business (2013-2018)(Million US$)
Figure DRG International, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2013-2018)
Table DRG International, Inc Recent Development
Table Fujirebio US, Inc Company Details
Table Fujirebio US, Inc Revenue in Tumor Markers Immunoassay Business (2013-2018)(Million US$)
Figure Fujirebio US, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2013-2018)
Table Fujirebio US, Inc Recent Development
Table Bioscience (Tianjin) Diagnostic Technology Co., Ltd Company Details
Table Bioscience (Tianjin) Diagnostic Technology Co., Ltd Revenue in Tumor Markers Immunoassay Business (2013-2018)(Million US$)
Figure Bioscience (Tianjin) Diagnostic Technology Co., Ltd Revenue Growth Rate in Tumor Markers Immunoassay Business (2013-2018)
Table Bioscience (Tianjin) Diagnostic Technology Co., Ltd Recent Development
Table Boson Biotech Co., Ltd Company Details
Table Boson Biotech Co., Ltd Revenue in Tumor Markers Immunoassay Business (2013-2018)(Million US$)
Figure Boson Biotech Co., Ltd Revenue Growth Rate in Tumor Markers Immunoassay Business (2013-2018)
Table Boson Biotech Co., Ltd Recent Development
Table Qualigen, Inc Company Details
Table Randox Laboratories, Ltd Company Details
Table Roche Diagnostic Corporation Company Details
Table Siemens Healthineers Company Details
Table Syntron Bioresearch, Inc Company Details
Table Teco Diagnostics Company Details
Table Thermo Fisher Scientific, Inc Company Details
Table Tosoh Bioscience, Inc Company Details
Table Diametra Company Details
Table DiaSorin S.p.A Company Details
Table Global Tumor Markers Immunoassay Market Size by Regions (Million US$) 2018-2025
Figure Global Tumor Markers Immunoassay Market Size Share by Regions (2018-2025)
Figure Global Tumor Markers Immunoassay Market Size Share by Regions in 2025
Figure United States Tumor Markers Immunoassay Market Size Forecast (2018-2025)(Million USD)
Figure Europe Tumor Markers Immunoassay Market Size Forecast (2018-2025)(Million USD)
Figure China Tumor Markers Immunoassay Market Size Forecast (2018-2025)(Million USD)
Figure Japan Tumor Markers Immunoassay Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Tumor Markers Immunoassay Market Size Forecast (2018-2025)(Million USD)
Figure India Tumor Markers Immunoassay Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Tumor Markers Immunoassay Market Size Forecast (2018-2025)(Million USD)
Table Global Tumor Markers Immunoassay Market Size by Product (2018-2025) (Million US$)
Figure Global Tumor Markers Immunoassay Market Size by Product (2018-2025)
Figure Global Tumor Markers Immunoassay Market Size by Product in 2025
Table Global Tumor Markers Immunoassay Market Size by Application (2018-2025) (Million US$)
Figure Global Tumor Markers Immunoassay Market Size by Application (2018-2025)
Figure Global Tumor Markers Immunoassay Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

* mark fields are compulsory